|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/10 | |
| A61P 1/00 | |||
| A61P 5/00 | |||
| A61P 9/00 |
| (11) | Number of the document | 2506865 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10796208.6 |
| Date of filing the European patent application | 2010-12-03 | |
| (97) | Date of publication of the European application | 2012-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2015-04-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/058848 |
| Date | 2010-12-03 |
| (87) | Number | WO 2011/069038 |
| Date | 2011-06-09 |
| (30) | Number | Date | Country code |
| 630654 | 2009-12-03 | US |
| (72) |
SHAILUBHAI, Kunwar, US
|
| (73) |
Synergy Pharmaceuticals Inc.,
420 Lexington Avenue Suite 1609, New York, NY 10170,
US
|
| (54) | AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA |
| AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA |